MasonR.G., ChuangH.Y.K., MohammadS.F., and SharpD.E..: Extracorporeal thrombogenesis and anticoagulation. p. 199. In: Replacement of renal function by dialysis.DrukkerW., ParsonsF.M., MaherJ.F.: eds. (Martinus Nijhoff, Boston1978).
2.
LindsayR.M., PrenticeC.R.M., DavidsonJ.F., BurtonJ.A., and McNicolG.P..: Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes.Br. Med. J.4: 454, 1972.
3.
Anticoagulants. Chapter 58, p. 1348. In: Goodman and Gilman's.The Pharmacological basis of therapeutics.Goodman GilmanA., GoodmanL., GilmanA.: eds. (McMillan Publishing Co., 1980).
4.
BlaggC.R.: Acute complication associated with hemodialysis. p. 498. In: Replacement of renal function by dialysis.DrukkerW., ParsonsF.M., MaherJ.F.: eds. (Martinus Nijhoff.Boston. 1978).
5.
LazarusJ.M.: Complications in hemodialysis: An overview.Kidney Int.18: 783, 1980.
LevinR.D., KwaanH.C., IvanovichP.: Changes in platelet function during hemodialysis.J. Lab. Clin. Med.92: 779, 1978.
8.
SwartzR.D., and PortF.K..: Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin.Kidney Int.16: 513, 1979.
9.
WoodsH.F., AshG., WestonM.J., BuntingS., MoncadaS., and VaneJ.R..: Prostacyclin can replace heparin in hemodialysis in dogs.Lancet.2: 1075, 1978.
10.
TurneyJ.H., FewellM.R., WilliamsL.C., ParsonsV., and WestonM.J..: Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.Lancet.2: 219, 1980.
11.
ArzeR.S., and WardM.K..: Prostacyclin safer than heparin in haemodialysis.Lancet.2: 50, 1981.
12.
ZusmanR.M., RubinR.H., CatoA.E., CocchettoD.M., CrowJ.W., and Tolkoff-RubinN..: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.N. Engl. J. Med.304: 934, 1981.
13.
SmithM.C., DanviriyasupK., CrowJ.W., CatoA.E., ParkG.D., HassidA., and DunnM.J..: Prostacyclin substitution for heparin in long-term hemodialysis.Amer. J. Med.73: 669, 1982.
14.
PinnickR.V., WiegmannT.B., DiederichD.A.: Regional anticoagulation for hemodialysis with sodium citrate as the sole anticoagulant.Kidney Int.21: 175, 1982.
15.
DuncanK., SeatonR., PinnickR., WiegmannT., and DiederichD..: Regional citrate anticoagulation for hemodialysis of patients with active bleeding.The American Society of Nephrology Abstracts. p. 54A, 1982.
16.
CasatiS., GrazianiG., and PonticelliC..: Hemodialysis without anticoagulants in patients with high bleeding risk.Intern. J. Artif. Org.5: 233, 1982.
17.
IvanovichP., XuC.G., WwaanH.C., and HathiwalaS..: Studies of coagulation and platelet functions in heparin-free hemodialysis. (Accepted for publication in Nephron).